• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Health Care Stocks Moving In Thursday's Intraday Session

    6/22/23 1:38:01 PM ET
    $AGLE
    $AHI
    $ALVR
    $EVLO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $AGLE alert in real time by email

    Gainers

    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares increased by 369.4% to $0.5 during Thursday's regular session. Trading volume for Aeglea BioTherapeutics's stock is 224.5 million as of 13:37 EST. This is 25346.5% of its average full-day volume over the last 100 days. The company's market cap stands at $32.6 million.
    • Talaris Therapeutics (NASDAQ:TALS) stock rose 22.95% to $2.71. Trading volume for this security as of 13:37 EST is 9.9 million, which is 3327.7% of its average full-day volume over the last 100 days. The company's market cap stands at $114.0 million.
    • Senseonics Holdings (AMEX:SENS) shares rose 19.61% to $0.93. Trading volume for Senseonics Holdings's stock is 13.6 million as of 13:37 EST. This is 272.3% of its average full-day volume over the last 100 days. The company's market cap stands at $446.2 million.
    • Sotera Health (NASDAQ:SHC) shares rose 18.26% to $17.74. Trading volume for this security as of 13:37 EST is 5.6 million, which is 631.2% of its average full-day volume over the last 100 days. The company's market cap stands at $5.0 billion.
    • Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 14.46% to $0.72. Trading volume for this security as of 13:37 EST is 3.5 million, which is 85.9% of its average full-day volume over the last 100 days. The company's market cap stands at $19.8 million.
    • MiNK Therapeutics (NASDAQ:INKT) shares rose 13.97% to $3.1. MiNK Therapeutics's stock is trading at a volume of 142.8K shares as of 13:37 EST. This is 90.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $106.7 million.

    Losers

    • Innovative Eyewear (NASDAQ:LUCY) shares fell 31.2% to $0.96 during Thursday's regular session. Trading volume for this security as of 13:37 EST is 6.6 million, which is 316.8% of its average full-day volume over the last 100 days. The company's market cap stands at $8.0 million.
    • AlloVir (NASDAQ:ALVR) shares fell 27.79% to $3.56. The current volume of 4.3 million shares is 1763.9% of AlloVir's average full-day volume over the last 100 days (last updated at 13:37 EST). The market value of their outstanding shares is at $333.1 million.
    • Mallinckrodt (AMEX:MNK) shares declined by 20.27% to $1.22. Trading volume for Mallinckrodt's stock is 331.9K as of 13:37 EST. This is 21.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.0 million.
    • Advanced Health (NASDAQ:AHI) stock fell 18.79% to $1.21. The current volume of 4.8 million shares is 92.6% of Advanced Health's average full-day volume over the last 100 days (last updated at 13:37 EST). The company's market cap stands at $33.8 million.
    • Evelo Biosciences (NASDAQ:EVLO) shares fell 17.19% to $0.13. Trading volume for this security as of 13:37 EST is 7.2 million, which is 77.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.8 million.
    • P3 Health Partners (NASDAQ:PIII) shares fell 16.82% to $3.66. As of 13:37 EST, this security is trading at a volume of 365.9K shares, making up 69.5% of its average full-day volume over the last 100 days. The company's market cap stands at $414.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AGLE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGLE
    $AHI
    $ALVR
    $EVLO

    CompanyDatePrice TargetRatingAnalyst
    Sotera Health Company
    $SHC
    1/9/2026$24.00Neutral → Overweight
    Piper Sandler
    Sotera Health Company
    $SHC
    1/9/2026$24.00Outperform
    RBC Capital Mkts
    Sotera Health Company
    $SHC
    12/18/2025Outperform
    William Blair
    Sotera Health Company
    $SHC
    11/13/2025$19.00Outperform
    BMO Capital Markets
    Senseonics Holdings Inc.
    $SENS
    10/21/2025$9.00Hold
    Stifel
    P3 Health Partners Inc.
    $PIII
    8/28/2025$20.00Buy
    Lake Street
    Senseonics Holdings Inc.
    $SENS
    8/27/2025$1.50Overweight
    Barclays
    MiNK Therapeutics Inc.
    $INKT
    8/15/2025$35.00Neutral → Buy
    H.C. Wainwright
    More analyst ratings

    $AGLE
    $AHI
    $ALVR
    $EVLO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gross Harrison R. bought $1,980 worth of shares (1,500 units at $1.32), increasing direct ownership by 12% to 13,733 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/22/26 11:29:05 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Financial Officer Gayle Oswald bought $1,669 worth of shares (1,000 units at $1.67), increasing direct ownership by 54% to 2,865 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/15/26 5:00:07 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Executive Officer Gross Harrison R. bought $2,400 worth of shares (1,500 units at $1.60), increasing direct ownership by 14% to 12,233 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/12/26 5:00:39 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $AGLE
    $AHI
    $ALVR
    $EVLO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Warburg Pincus & Co. sold $229,050,000 worth of shares (15,000,000 units at $15.27) (SEC Form 4)

    4 - Sotera Health Co (0001822479) (Issuer)

    3/10/26 7:50:42 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    Director Warburg Pincus & Co. sold $229,050,000 worth of shares (15,000,000 units at $15.27) (SEC Form 4)

    4 - Sotera Health Co (0001822479) (Issuer)

    3/10/26 7:49:10 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    Director Gtcr Investment Xi Llc sold $152,700,000 worth of shares (10,000,000 units at $15.27) (SEC Form 4)

    4 - Sotera Health Co (0001822479) (Issuer)

    3/10/26 6:10:40 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    $AGLE
    $AHI
    $ALVR
    $EVLO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Innovative Eyewear, Inc. Announces Q4 and Full Year 2025 Earnings Conference Call

    MIAMI, March 10, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, today announced its upcoming earnings conference call to share the Company's key operational and financial results for the fiscal year ended December 31, 2025. Earnings Call DetailsDate: Tuesday, March 31, 2026Time: 12:00 PM ETParticipant Listening OptionsInterested participants can join the event by using the dial-in numbers, or by cl

    3/10/26 4:30:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Sotera Health Announces Secondary Offering of Common Stock

    CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 25 million shares of its common stock, par value $0.01 per share. All 25 million shares are being offered for sale by certain affiliates of Warburg Pincus LLC ("Warburg Pincus") and GTCR LLC ("GTCR") as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Regist

    3/4/26 4:51:01 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration, with twiist in the US GERMANTOWN, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ:SENS) a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced fourth quarter 2025 financial results and provided a business update. Recent Highlights & Accomplishments Generated fourth quarter 2025 revenue of $14.3 million, an increase

    3/2/26 4:01:00 PM ET
    $SENS
    Medical/Dental Instruments
    Health Care

    $AGLE
    $AHI
    $ALVR
    $EVLO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sotera Health upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Sotera Health from Neutral to Overweight and set a new price target of $24.00

    1/9/26 8:33:00 AM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    RBC Capital Mkts resumed coverage on Sotera Health with a new price target

    RBC Capital Mkts resumed coverage of Sotera Health with a rating of Outperform and set a new price target of $24.00

    1/9/26 8:12:05 AM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    William Blair initiated coverage on Sotera Health

    William Blair initiated coverage of Sotera Health with a rating of Outperform

    12/18/25 9:11:03 AM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    $AGLE
    $AHI
    $ALVR
    $EVLO
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Sotera Health Company

    SCHEDULE 13G/A - Sotera Health Co (0001822479) (Subject)

    3/10/26 7:47:15 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 8-K filed by Sotera Health Company

    8-K - Sotera Health Co (0001822479) (Filer)

    3/6/26 5:29:19 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 424B7 filed by Sotera Health Company

    424B7 - Sotera Health Co (0001822479) (Filer)

    3/5/26 4:11:20 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    $AGLE
    $AHI
    $ALVR
    $EVLO
    Leadership Updates

    Live Leadership Updates

    View All

    Sotera Health Appoints Richard Kyle to the Board of Directors

    CLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced today it has appointed Richard G. Kyle as a new independent director to its Board of Directors. Mr. Kyle will serve as a member of the Leadership Development and Compensation Committee and the Nominating and Corporate Governance Committee of the Board of Directors. Most recently, Mr. Kyle served as President and Chief Executive Officer of The Timken Company ("Timken") (NYSE:TKR), a global manufacturer of bearings, transmissions, and industrial motion produc

    2/5/26 7:30:00 AM ET
    $SHC
    $SON
    $TKR
    Misc Health and Biotechnology Services
    Health Care
    Containers/Packaging
    Consumer Discretionary

    Vistagen Appoints Nick Tressler as Chief Financial Officer

    Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced the appointment of Nick Tressler as Chief Financial Officer (CFO), effective today, December 1, 2025. "I am excited to welcome Nick to Vistagen as our CFO. His financial and strategic acumen and extensive operational experience in the biopharmaceutical industry will be instrumental as we accelerate into our next phase," said President and Chief Executive Officer of Vistagen, Shawn Singh. "I look forward to his contributions to our leadership team and the po

    12/1/25 8:30:00 AM ET
    $AZN
    $SENS
    $VTGN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    MiNK Therapeutics Appoints Colonel (Ret.) John B. Holcomb, MD, to Board of Directors

    NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering invariant natural killer T (iNKT) cell therapies, today announced the appointment of Colonel (Ret.) John B. Holcomb, MD, FACS to its Board of Directors. Dr. Holcomb is a globally recognized authority in trauma and critical care, having served 23 years in the U.S. Army, including as Commander of the U.S. Army Institute of Surgical Research and Trauma Consultant to the Army Surgeon General. He pioneered major innovations in combat casualty care, transfusion medicine, and trauma systems design that saved countless lives and reshaped global health protocol

    9/29/25 7:30:00 AM ET
    $INKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGLE
    $AHI
    $ALVR
    $EVLO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sotera Health Company

    SC 13G/A - Sotera Health Co (0001822479) (Subject)

    11/14/24 4:51:55 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sotera Health Company

    SC 13G/A - Sotera Health Co (0001822479) (Subject)

    11/14/24 4:50:09 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by P3 Health Partners Inc.

    SC 13G - P3 Health Partners Inc. (0001832511) (Subject)

    11/14/24 4:33:46 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $AGLE
    $AHI
    $ALVR
    $EVLO
    Financials

    Live finance-specific insights

    View All

    Innovative Eyewear, Inc. Announces Q4 and Full Year 2025 Earnings Conference Call

    MIAMI, March 10, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, today announced its upcoming earnings conference call to share the Company's key operational and financial results for the fiscal year ended December 31, 2025. Earnings Call DetailsDate: Tuesday, March 31, 2026Time: 12:00 PM ETParticipant Listening OptionsInterested participants can join the event by using the dial-in numbers, or by cl

    3/10/26 4:30:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration, with twiist in the US GERMANTOWN, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ:SENS) a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced fourth quarter 2025 financial results and provided a business update. Recent Highlights & Accomplishments Generated fourth quarter 2025 revenue of $14.3 million, an increase

    3/2/26 4:01:00 PM ET
    $SENS
    Medical/Dental Instruments
    Health Care

    Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook

    2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 20242025 Adjusted EBITDA(1) increased 8.2% to $594 million, compared to 2024, or 7.8% on a constant currency basis2025 Adjusted EPS(1) of $0.86, an increase of $0.16 per diluted share, compared to 2024Full-year 2026 outlook: net revenues growth of 5.0% to 6.5% and Adjusted EBITDA growth of 5.5% to 7.0%, on a constant currency basis CLEVELAND, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company ("Sotera Health" or the "Company") (NASDAQ:SHC),

    2/24/26 7:00:00 AM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care